跳至主要内容
临床试验/TCTR20170906002
TCTR20170906002已完成4 期

The Study of Glycemic Index of NEO-MUNE

Thai Otsuka Pharmaceutical Co., Ltd.0 个研究点目标入组 10 人开始时间: 2017年9月6日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
10

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 0 N/A (No limit)(—)
性别
All

入选标准

  • 1.18 years of age as the minimum age
  • 2.Body Mass Index in the range of 18.5 - 24.9 kg/m2
  • 3.Do not have any underlying disease
  • 4.Do not have a family history of diabetes
  • 5.Do not have any allergy of any component in the formula such as protein in cow milk, Glutamine, Arginine, fish oil etc.
  • 6.Consent to participate the study and sign in the consent form with the understanding of detail and be able to follow the process

排除标准

  • 1.Having underlying disease such as diabetes, hypertension, heart and vascular disease, hepatic disease, kidney disease and disease which affect the metabolism such as thyroid disease etc.
  • 2.Having medication, dietary supplement and vitamin within 7 days prior to the study
  • 3.Pregnant or breastfeeding subject
  • 4.Unable to follow the study process

研究者

发起方
Thai Otsuka Pharmaceutical Co., Ltd.

相似试验

The Study of Glycemic Index of NEO-MUNE | 临床试验